Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-02

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application to authorize a preservative-free version of dorzolamide hydrochloride and timolol maleate eye drops for lowering intraoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride and timolol maleate (preservative-free) (Dorzolamide hydrochloride and timolol maleate preservative-free)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE)